Physiologically Based Pharmacokinetic Modeling of Elexacaftor–Tezacaftor–Ivacaftor in Adults and Pediatric People with Cystic Fibrosis: Exploring Brain Exposure and Neuropsychiatric Adverse Events
- DOI
- 10.1007/s40262-026-01712-7
- Published
- 2026-10-09
- Container
- Clinical Pharmacokinetics
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40262-026-01712-7,
title = {Physiologically Based Pharmacokinetic Modeling of Elexacaftor–Tezacaftor–Ivacaftor in Adults and Pediatric People with Cystic Fibrosis: Exploring Brain Exposure and Neuropsychiatric Adverse Events},
author = {Clotilde Vellat and Laurent Bourguignon and Sabine Cohen and Philippe Reix and Romain Garreau},
year = {2026},
journal = {Clinical Pharmacokinetics},
doi = {10.1007/s40262-026-01712-7},
url = {https://doi.org/10.1007/s40262-026-01712-7}
}RIS
TY - JOUR TI - Physiologically Based Pharmacokinetic Modeling of Elexacaftor–Tezacaftor–Ivacaftor in Adults and Pediatric People with Cystic Fibrosis: Exploring Brain Exposure and Neuropsychiatric Adverse Events AU - Clotilde Vellat AU - Laurent Bourguignon AU - Sabine Cohen AU - Philippe Reix AU - Romain Garreau PY - 2026 JO - Clinical Pharmacokinetics DO - 10.1007/s40262-026-01712-7 UR - https://doi.org/10.1007/s40262-026-01712-7 ER -
APA
Vellat, C., Bourguignon, L., Cohen, S., Reix, P., & Garreau, R. (2026). Physiologically Based Pharmacokinetic Modeling of Elexacaftor–Tezacaftor–Ivacaftor in Adults and Pediatric People with Cystic Fibrosis: Exploring Brain Exposure and Neuropsychiatric Adverse Events. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-026-01712-7
Source records
- crossref · retrieved 2026-11-10T06:39:11.344Z